Researchers have discovered that measuring levels of three cerebrospinal fluid (CSF) biomarkers could help diagnose Alzheimer's disease. They identified a specific signature that was present in 90% of patients with the disorder. It was also found in 36% of the control group, who were cognitively ...
Please Login to read the full article.
